Healthcare Industry
An ETH Zurich team has built millions of stem-cell-infused injectable nanorobots that helped paralysed mice regain movement within weeks, hinting at a faster future route to repairing spinal injuries.
Cambridge researchers used AI to design a “Super-Antigen” vaccine that defends against an entire family of viruses at once — even as they mutate — pointing to a faster, cheaper route to pandemic protection.
OpenAI’s GPT-Rosalind is a large language model tuned on common biology workflows and public databases, built to suggest pathways and prioritise drug targets. Citing bioweapon risk, OpenAI is limiting access to vetted US-based researchers for now.
WHY THIS MATTERS IN BRIEF What if you could take any cell, reprogram it, and turn it into any other…
WHY THIS MATTERS IN BRIEF Humanoid robots are getting more realistic quickly and this is the latest in a long…
WHY THIS MATTERS IN BRIEF The ability to track the lifecycle of an individual cell down to the nanoscale opens…
WHY THIS MATTERS IN BRIEF The use of digital twins and smart factories is revolutionising the manufacturing and R&D process,…
WHY THIS MATTERS IN BRIEF In the future almost all drugs could be developed in silico at unimaginable speeds. …
WHY THIS MATTERS IN BRIEF AI companies want to automate science and scientific discovery and they’re making progress. Matthew…
WHY THIS MATTERS IN BRIEF The ability to see through blood during surgeries improves the safety and effectiveness of those…
WHY THIS MATTERS IN BRIEF What if AI could start democratising science and scientific discovery in the same way that…
WHY THIS MATTERS IN BRIEF Cellular amplification triples editing reach with lower doses, making systemic genetic treatments significantly more efficient…